| Course | HCR 561 Responsible Conduct of Clinical Research |
|---|---|
| Module | Module 5 |
| Paper type | Research ethics essay |
| Length | About 749 words, 5 pages |
| Format | APA 7 student paper |
| School | Arizona State University |
| Program | MS in Clinical Research Management |
| Updated | October 2026 |
Free sample paper for HCR 561 Module 5
Healthy but Vulnerable: Serial Paid Volunteers in Phase I Trials and the Limits of Federal Protections
Student Name
MS in Clinical Research Management, Arizona State University
HCR 561: Responsible Conduct of Clinical Research
Instructor Name
Month Day, Year
Healthy but Vulnerable: Serial Paid Volunteers in Phase I Trials and the Limits of Federal Protections
Introduction
Federal research regulations name certain groups as needing additional protection: pregnant women, fetuses and neonates, prisoners and children (45 C.F.R. §§ 46.201-46.409). Their vulnerability is clear. This essay argues for attention to a group that looks like the opposite: healthy adults who are paid to test new drugs in Phase I trials. Many of them enroll repeatedly, depend on the income and come from groups with fewer economic options. Their vulnerability is not medical; it is economic and structural, and it deserves protection in its own right.
What Makes a Population Vulnerable
Vulnerability in research ethics means an increased likelihood of being wronged or harmed, usually because a person's capacity to protect their own interests is limited. The limit can be cognitive, as with impaired decision-making; institutional, as with prisoners; or economic and social, when people have few alternatives and a strong need for the benefits a study offers (Emanuel et al., 2008). Economic vulnerability does not make consent invalid, but it raises the risk of undue influence and of a pattern of participation that no single review board can see.
Who Serial Healthy Volunteers Are
Phase I trials test first-in-human doses, drug interactions and other safety questions, mostly in healthy adults who receive no medical benefit and are paid for time and burden. In a longitudinal study of 178 U.S. healthy volunteers, nearly three quarters were men and two thirds belonged to racial or ethnic minority groups. Those who completed the most trials over the longest periods were more likely to be Black, Hispanic, unemployed or living on household incomes below $25,000, and those who pursued trials as a full-time job participated most (Kalbaugh et al., 2021).
How They Weigh Risk
It would be easy to assume these volunteers do not understand the risks. The evidence suggests otherwise. Interviewed about their experience in a combined 1,948 trials, volunteers were generally aware of and reflective about Phase I risks, but they often judged the risks of trials in general as higher than their own personal risk, a gap that helps explain continued enrollment (Fisher et al., 2018). Understanding is present; what shapes the choice is need.
What They Actually Earn
Phase I compensation can look large for a single study, which raises concern about undue inducement. Yet tracked over three years, volunteers earned a median of about $3,070 per trial and roughly $4,000 a year, and it was rare for anyone to earn more than $20,000 in a year (Fisher et al., 2021). The authors suggest that the larger problem may not be single high payments but the unrealistic belief that trials can provide a living. For participants with few alternatives, repeated enrollment becomes a form of precarious work without the protections that come with employment.
Why Current Protections Fall Short
Each Phase I trial is reviewed by an IRB that sees one study, one payment and one consent process. No board sees a volunteer's cumulative exposure across trials at different sites. Washout periods between studies depend on volunteers' honesty, and some conceal recent participation to qualify. Federal rules do not classify economically disadvantaged adults as a protected subpart, so protections depend on individual boards' judgment. The result is a population whose risks are concentrated and largely invisible to oversight.
Proposed Protections
| Protection | Purpose |
|---|---|
| National Phase I participant registry | Prevents overlapping enrollment and enforces washout periods across sites |
| Payment schedules that pay for time, not risk | Reduces inducement to accept riskier studies |
| Plain disclosure of typical annual earnings | Corrects the belief that trials can be a full-time income |
| Injury compensation and follow-up care | Gives volunteers protection comparable to workers |
| Community advisory input at Phase I units | Brings volunteers' perspective into study design |
Counterarguments
Some argue that treating paid volunteers as vulnerable is paternalistic, since they understand risks and choose freely. That concern is fair: the aim is not to exclude them but to remove avoidable harms, such as overlapping trials, and to give them protections workers already have. Others argue that registries threaten privacy; a registry can store only identifiers and dates, not health data.
Conclusion
Healthy volunteers in Phase I trials are not vulnerable because they cannot understand research. They are vulnerable because economic need concentrates the burden of first-in-human testing on people with few alternatives, and because no one sees their total exposure. Naming that vulnerability is the first step toward protections that respect their choice while reducing their risk.
References
Additional protections for pregnant women, prisoners and children, 45 C.F.R. §§ 46.201-46.409 (2025).
Emanuel, E. J., Grady, C. C., Crouch, R. A., Lie, R. K., Miller, F. G., & Wendler, D. D. (Eds.). (2008). The Oxford textbook of clinical research ethics. Oxford University Press.
Fisher, J. A., McManus, L., Cottingham, M. D., Kalbaugh, J. M., Wood, M. M., Monahan, T., & Walker, R. L. (2018). Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study. PLOS Medicine, 15(11), e1002698. https://doi.org/10.1371/journal.pmed.1002698
Fisher, J. A., McManus, L., Kalbaugh, J. M., & Walker, R. L. (2021). Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment? Clinical Trials, 18(4), 477-487. https://doi.org/10.1177/17407745211011069
Kalbaugh, C. A., Kalbaugh, J. M., McManus, L., & Fisher, J. A. (2021). Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time. PLOS ONE, 16(9), e0256994. https://doi.org/10.1371/journal.pone.0256994
HCR 561 Module 5 instructions, in plain terms
Assignment 2 in HCR 561 is an essay on vulnerable populations, due in Week 5. That week's topics are a guide to what fits: informed consent and review in multinational research, adults with impaired decision-making capacity, research with children, fetuses, embryos and stem cells, research with healthy volunteers and identifiable and targeted communities. The full instructions and rubric sit in Canvas. An essay works best when it argues something rather than surveying every protected group: why a particular population is vulnerable, how current protections work or fall short and what should change. The federal regulations' subparts for pregnant women, prisoners and children are the starting point for what the law already recognizes, and the Oxford Textbook of Clinical Research Ethics offers frameworks for thinking about vulnerability beyond those categories.
How this HCR 561 Module 5 example is built
The sample states a clear thesis in the introduction: a group the regulations do not name is vulnerable in a way they do not address. A section defines vulnerability with the course text's framework. Three evidence sections follow, each built on one study: who serial volunteers are, how they weigh risk and what they earn. A section explains why one-study-at-a-time review misses the problem. A table pairs each proposed protection with what it accomplishes, a section takes on the charge of paternalism and the final paragraph returns to the thesis with the evidence behind it. Each evidence section reports numbers from its study, so the argument rests on data rather than assumptions about who volunteers.
Reading the HCR 561 Module 5 grading rubric
The vulnerable populations essay is scored on its Canvas rubric within the 350 points for the course's assignments. Credit goes to a clear definition of vulnerability, an accurate account of the population chosen, evidence from research rather than assumption, a fair assessment of how current regulations and oversight apply, specific proposed protections and engagement with counterarguments, in clean academic prose with APA citations. Marks drop when an essay lists all vulnerable groups without depth, when claims about a population are unsupported, when the regulatory framework is misstated and when recommendations are vague. Readers value essays that challenge an assumption with evidence, since the course aims to build independent ethical judgment.
HCR 561 Module 5 help: mistakes that cost marks
Pick one population and make a claim about it in one sentence. Define vulnerability using the course text, then show which kind applies. Use studies, not opinion, to describe the population. Check what the federal subparts actually say before you discuss gaps. Propose specific protections and say what each does. Answer the strongest objection to your argument. If you are deciding between populations, the desk can suggest ones with good recent evidence. Use people-first language for the population you write about, describing circumstances rather than labels. Finally, keep your proposals proportionate, since protections that make participation impossible would harm the people they are meant to help.
Write yours, or have the desk draft it
This paper is an original model document written by our desk, not a submitted student paper and not an official Arizona State University document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.
More HCR 561 and MS in Clinical Research Management sample papers
- HCR 561 Module 3: Assignment 1: Slides for Site Staff on an Ethical Issue
- HCR 566 Module 11: Final Capstone Paper
- HCR 558 Module 4: FDA Warning Letter: Response
- HCR 593 Module 1: Applied Project Proposal
- HCR 575 Module 7: Assignment 5: Negotiating the Sponsor's Budget
HCR 561 Module 5 questions, answered
Where can I find a free HCR 561 Module 5 sample paper?
The page above has a full Assignment 2 essay arguing that serial paid Phase I volunteers are a vulnerable population.
Which populations do federal research rules give extra protection?
Pregnant women, fetuses and neonates, prisoners and children, under subparts B, C and D of 45 C.F.R. Part 46.
Are healthy volunteers in Phase I trials a vulnerable population?
They are not named in the rules, but economic need and repeated enrollment can make them vulnerable to undue influence and hidden cumulative risk.
How much do Phase I healthy volunteers earn?
In a three-year U.S. study, the median was about $3,070 per trial and roughly $4,000 a year.
What makes someone vulnerable in research ethics?
An increased chance of being wronged or harmed because cognitive, institutional or economic limits reduce their ability to protect their interests.